Stay updated on Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.

Latest updates to the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedNew study sites were added across multiple US states and internationally (New South Wales, Victoria, Manitoba, Ontario, Quebec, Hokkaido, Osaka, Tokyo) with revision to v3.3.3. The prior location list (v3.3.2) and the HHS Vulnerability Disclosure entry were removed.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision label 'Revision: v3.3.2' has been added and the previous label 'Revision: v3.2.0' has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedNotice about government funding lapse removed from the page. Core study information including objectives, design, outcomes, and locations remains unchanged.SummaryDifference0.2%

- Check48 days agoChange DetectedThe new image shows only minor formatting/layout differences on the Study Details page; core content such as eligibility criteria, endpoints, and results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check85 days agoChange DetectedPage version updated to v3.1.0; several MedlinePlus topics were removed.SummaryDifference0.3%

Stay in the know with updates to Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of PF-06700841 Cream in Atopic Dermatitis Clinical Trial page.